Ligand Pharmaceuticals Inc
NASDAQ:LGND

Watchlist Manager
Ligand Pharmaceuticals Inc Logo
Ligand Pharmaceuticals Inc
NASDAQ:LGND
Watchlist
Price: 189.07 USD -0.59% Market Closed
Market Cap: 3.7B USD

Intrinsic Value

The intrinsic value of one LGND stock under the Base Case scenario is 119.88 USD. Compared to the current market price of 189.07 USD, Ligand Pharmaceuticals Inc is Overvalued by 37%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

LGND Intrinsic Value
119.88 USD
Overvaluation 37%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Ligand Pharmaceuticals Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about LGND?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is LGND valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Ligand Pharmaceuticals Inc.

Explain Valuation
Compare LGND to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about LGND?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Ligand Pharmaceuticals Inc

Current Assets 753.9m
Cash & Short-Term Investments 664.5m
Receivables 58.1m
Other Current Assets 31.3m
Non-Current Assets 722.9m
Long-Term Investments 148.7m
PP&E 11.1m
Intangibles 541.4m
Other Non-Current Assets 21.6m
Current Liabilities 30.5m
Accounts Payable 3.7m
Accrued Liabilities 24.6m
Other Current Liabilities 2.3m
Non-Current Liabilities 496.1m
Long-Term Debt 445.5m
Other Non-Current Liabilities 50.6m
Efficiency

Free Cash Flow Analysis
Ligand Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Ligand Pharmaceuticals Inc

Revenue
251.2m USD
Cost of Revenue
-14.4m USD
Gross Profit
236.8m USD
Operating Expenses
-208m USD
Operating Income
28.8m USD
Other Expenses
19.7m USD
Net Income
48.6m USD
Fundamental Scores

LGND Profitability Score
Profitability Due Diligence

Ligand Pharmaceuticals Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
ROE is Increasing
Gross Margin is Increasing
50/100
Profitability
Score

Ligand Pharmaceuticals Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

LGND Solvency Score
Solvency Due Diligence

Ligand Pharmaceuticals Inc's solvency score is 88/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
88/100
Solvency
Score

Ligand Pharmaceuticals Inc's solvency score is 88/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LGND Price Targets Summary
Ligand Pharmaceuticals Inc

Wall Street analysts forecast LGND stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LGND is 248.31 USD with a low forecast of 222.2 USD and a high forecast of 288.75 USD.

Lowest
Price Target
222.2 USD
18% Upside
Average
Price Target
248.31 USD
31% Upside
Highest
Price Target
288.75 USD
53% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for LGND is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

LGND Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one LGND stock?

The intrinsic value of one LGND stock under the Base Case scenario is 119.88 USD.

Is LGND stock undervalued or overvalued?

Compared to the current market price of 189.07 USD, Ligand Pharmaceuticals Inc is Overvalued by 37%.

Back to Top